However, different types of leukaemia need different sorts of treatment. Molecular analysis provides a rapid and accurate diagnosis and will ensure that the most appropriate treatment is given to each patient. Notes to Newsdesk A Government grant of 353,000 was awarded to Professor Tony Green and Dr Mike Scott from the Department of Haematology to modernise Pathology Services when the award was announced last year as part of the NHS Plan. They are an integral part of effective NHS diagnosis and treatment, patient care and screening programmes and so have a critical place in protecting and improving public health. Haematological malignancies have an incidence of approximately 80 per 100,000 and include acute leukaemia, chronic leukaemia, lymphomas, myleoma and a variety of pre-leukaemic conditions.
Many haematological malignancies are curable.
Accurate diagnosis is essential to maximise the chances of cure and to ensure appropriate use of expensive resources. Allow the development of a comprehensive regional Haemato-Oncology Diagnostic Service. Provide more rapid diagnosis. Improve quality of care by increasing diagnostic accuracy leading to the most appropriate choice of treatment for potentially curable disease. Provide equality of access to a centralised service by a single centre with specialist expertise.